DNA and Mitochondrial Time Bombs
Uranium, Mercury, Cancer and Diabetes
Hyperinsulinemia may promote mammary carcinogenesis.
Insulin resistance has been linked to an increased risk
of breast cancer and is also characteristic of type 2 diabetes.[1]
Diabetes and cancer both are expanding almost exponentially in the world today, can in part be traced to the increasing radiation to which we are all being exposed. Every physician knows that radiation can lead to cancer, but making a connection between radiation and diabetes seems ludicrous at first glance is anything but. Most medical doctors have never heard of this but neither have they paid attention to the fact that mercury and other toxic chemicals are also primary causes of diabetes. Even though there is little research into the connection between radiation poisoning and diabetes we should not remain blind, deaf and dumb about it.
Diabetes is a fundamental disease that affects the entire colony
of cells in a person because it has to do with energy metabolism
and the vastly important hormone insulin and its receptor sites.
Thus it comes as no surprise that we find diabetes and cancer intimately linked. About 80% of pancreatic cancer patients have glucose intolerance or frank diabetes. This observation has led medical scientists to believe that pancreatic cancer causes the associated diabetes and also those conditions associated with diabetes promote the development of pancreatic cancer.[2] A study, published by the American Medical Association in 2005, of more than 1 million South Koreans suggests diabetes can raise the risk of developing and dying from several types of cancer, including digestive-tract tumors.[3] We can thus say with reasonable confidence that whatever is causing diabetes is also, in part, causing cancer.
“Depleted (DU) uranium is highly toxic to humans, both chemically as a heavy metal and radiological as an alpha particle emitter, is very dangerous when taken internally,” writes Dr. Rosalie Bertell, Canadian Epidemiologist.[4] A new study, conducted by biochemist Dr. Diane Stearns at Northern Arizona University confirms that, separate from any radiation risks, cells exposed to uranium will bond with the metal chemically.[5] Uranium and phosphate have a strong chemical affinity for each other and the DNA and Mitochondria are loaded with phosphate so uranium is a DNA and Mitochondria deep penetration bomb. The uranium is attacking on fundamental cellular levels while mercury offers a knock out punch by attacking the sulfur bonds besides being highly toxic to nerve cells.
Diabetes is often conceptualized as a severe imbalance of part of
endocrine system that destroys our ability to metabolize food.
The imbalance results in elevated levels of insulin, a lack of insulin,
or the cell insulin receptor sites becoming insensitive to insulin.
Metals such as iron, mercury, arsenic, lead and possibly aluminum play a role in the actual destruction of beta cells through stimulating an auto-immune reaction to them after they have bonded to these cells in the pancreas. It is well documented in the medical literature that chemicals and drugs can cause temporary or permanent insulin-dependent diabetes.
Both mercury and uranium oxide are floating in the
environment like invisible clouds that have spread out everywhere.
They are raining down on us, damaging and damning our future.
Simultaneous exposure to mercury and uranium shows markedly increased damage to the kidneys than when exposure is to each metal singly. Insulin has three sulfur-containing cross-linkages and the insulin receptor has a tyrosine kinase-containing sulfur bond, which are the preferred targets for binding by both mercury and lead. Should mercury attach to one of these three sulfur bonds it will interfere with the normal biological function of the insulin molecule. Nephrotoxicity of the kidneys with necrosis of proximal tubules has been seen to increase significantly with dual exposure to both uranium and mercury.[6] In February, 2007 The Canadian Institute for Health Information (CIHI) reported that the number of new cases of kidney failure jumped 114 per cent. The burden of renal disease is also growing rapidly in India. The mean age of ESRD patients requiring dialysis in India is 32-42 years compared to the 60-63 years in the developed world. Chronic kidney disease (CKD) is a worldwide public health problem.[7]
[1] Diabetes Care. 2003 Jun;26(6):1752-8. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Michels KB
[2]The relationship between diabetes and pancreatic cancer Feng Wang . Surgery Department, Karolinska Institute at Huddinge University Hospital, 141 86 Stockholm, Sweden Department of Biology, Adams State College, Alamosa, CO 81102, USA
Molecular Cancer 2003, 2:4doi:10.1186/1476-4598-2-4
[5] A radioisotope of an element will bind best to the same substrates which a non-radioactive isotope of the same element will bind. Dr. Stearns has established that when cells are exposed to uranium, the uranium binds to DNA and the cells acquire mutations, triggering a whole slew of protein replication errors, some of which can lead to various cancers. Stearns’ research, published in the journals Mutagenesis and Molecular Carcinogenesis, confirms what many have suspected for some time – that uranium can damage DNA as a heavy metal, independent of its radioactive properties. The biochemical reaction of heavy metals can cause genetic mutations, which in turn can curtail cell growth and cause cancer. Heavy metals that are also radioactive amplify this effect and can cause distortions in shape and thus function even of red blood cells.
[6] Biol Trace Elem Res. 2001 Winter;84(1-3):139-54.
[7] In February, 2007 The Canadian Institute for Health Information (CIHI) reported that the number of new cases of kidney failure jumped 114 per cent, from just fewer than 1,100 in the first year to more than 2,100 cases in 2004, adding that the incidence of Type 2 diabetes jumped during the same period. In the United States (US), there is a rising incidence and prevalence of kidney failure. The number of patients enrolled in the end-stage renal disease (ESRD) Medicare-funded program has increased from approximately 10,000 beneficiaries in 1973 to 86,354 in 1983, and to 452,957 as of December 31, 2003. In 2003 alone 100,499 patients entered the US ESRD program.
Leave your response!